Portfolio News | October 27, 2005

NxStage Medical, Inc. Sets Price For Initial Public Offering Lawrence, MA – October 27, 2005 : NxStage Medical, Inc. today announced the initial public offering of 5,500,000 shares of its common stock at a price of $10.00 per share, before underwriting discounts and...

Portfolio News | May 19, 2006

Quest Diagnostics to Acquire Focus Diagnostics, Inc., A World Leader in Infectious Disease Testing LYNDHURST, N.J., and HERNDON, Va., May 19 /PRNewswire-FirstCall/ — Quest Diagnostics Incorporated (NYSE: DGX), the nation’s leading provider of diagnostic...

Portfolio News | August 2, 2006

Cerexa Reports Positive Top-Line Results for Phase 2 Clinical Trial of Ceftaroline Broad-Spectrum Anti-Infective Achieves Excellent Clinical, Microbiological Cure Rates for cSSSI Compared to Standard Therapy ALAMEDA, Calif., Aug. 2, 2006 — Cerexa Inc. today...

Portfolio News | October 12, 2006

eHealth, Inc. Announces Pricing of its Initial Public Offering of Common Stock MOUNTAIN VIEW, California – October 12, 2006 – eHealth, Inc. today announced the pricing of its initial public offering of 5,000,000 shares of common stock at a price of $14.00...

Portfolio News | December 20, 2006

Affymax(R) Announces Completion of Common Stock Offering PALO ALTO, Calif., Dec 20, 2006 /PRNewswire-FirstCall via COMTEX News Network/ — Affymax, Inc. (Nasdaq: AFFY), a clinical-stage pharmaceutical company, today announced the completion of its initial public...

Portfolio News | February 7, 2007

NxStage(R) Medical and DaVita Announce Agreement for Home Hemodialysis Using the NxStage System One(TM) LAWRENCE, Mass., Feb. 7 /PRNewswire-FirstCall/ — NxStage Medical, Inc. (Nasdaq: NXTM), the manufacturer of the NxStage System One(TM) portable kidney dialysis...
quis, Praesent Aenean id, consequat. ut nec ut in libero nunc libero.